<?xml version="1.0" encoding="utf-8"?>
<androidx.constraintlayout.widget.ConstraintLayout xmlns:android="http://schemas.android.com/apk/res/android"
    xmlns:app="http://schemas.android.com/apk/res-auto"
    xmlns:tools="http://schemas.android.com/tools"
    android:layout_width="match_parent"
    android:layout_height="match_parent"
    android:background="#bbd"
    tools:context=".pneumococcal">

    <TextView
        android:id="@+id/textView"
        android:layout_width="wrap_content"
        android:layout_height="wrap_content"
        android:text="Pneumococcal Vaccine"
        android:textColor="#000"
        android:textSize="40dp"
        android:gravity="center"
        android:textStyle="bold"
        app:layout_constraintBottom_toBottomOf="parent"
        app:layout_constraintEnd_toEndOf="parent"
        app:layout_constraintStart_toStartOf="parent"
        app:layout_constraintTop_toTopOf="parent"
        app:layout_constraintVertical_bias="0.047" />

    <ScrollView
        android:layout_width="373dp"
        android:layout_height="599dp"
        app:layout_constraintBottom_toBottomOf="parent"
        app:layout_constraintEnd_toEndOf="parent"
        app:layout_constraintStart_toStartOf="parent"
        app:layout_constraintTop_toTopOf="parent"
        app:layout_constraintVertical_bias="0.732">

        <TextView
            android:id="@+id/textView7"
            android:textColor="#000"
            android:layout_width="375dp"
            android:layout_height="650dp"
            android:background="@drawable/dashboard"
            android:padding="15dp"
            android:text="• Currently available PCVs are safe and effective and are therefore recommended for the inclusion
in childhood immunization programmes worldwide.\n\n• Use of pneumococcal vaccine should be complementary to other disease prevention and control
measures, such as appropriate case management, promotion of exclusive breastfeeding for the
first 6 months of life and reducing known risk factors such as indoor air pollution and tobacco
smoke.\n\n• For administration of PCV to infants, WHO recommends a 3-dose schedule administered either
as 2p+1 or as 3p+0, starting as early as 6 weeks of age.\n\n• If the 2p+1 schedule is selected, an interval of ≥8 weeks is recommended between the 2 primary
doses the booster dose should be given at 9–18 months of age, according to programmatic
considerations; there is no defined minimum or maximum interval between the primary series
and the booster dose.
\n\n• If the 3p+0 schedule is used, a minimum interval of 4 weeks should be maintained between
doses.\n\n• Previously unvaccinated or incompletely vaccinated children who recover from invasive
pneumococcal disease (IPD) should be vaccinated according to the recommended ageappropriate regimens. Interrupted schedules should be resumed without repeating the previous
dose.\n\n• Both PCV10 and PCV13 have substantial impacts against pneumonia, vaccine-type IPD and
NP carriage. The choice of product to be used in a country should be based on programmatic
characteristics, vaccine supply, vaccine price, the local and regional prevalence of vaccine
serotypes and antimicrobial resistance patterns.
"
            android:textSize="20dp"
            app:layout_constraintBottom_toBottomOf="parent"
            app:layout_constraintEnd_toEndOf="parent"
            app:layout_constraintHorizontal_bias="0.555"
            app:layout_constraintStart_toStartOf="parent"
            app:layout_constraintTop_toTopOf="parent"
            app:layout_constraintVertical_bias="0.756" />
    </ScrollView>

</androidx.constraintlayout.widget.ConstraintLayout>